Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PermRock Royalty Trust Unit | PRT | Oct 31, 2024 | 3.85 | -1.28 |
Perpetua Resources | PPTA | Oct 31, 2024 | 10.23 | +0.15 |
Perrigo | PRGO | Oct 31, 2024 | 25.63 | +0.79 |
Personalis | PSNL | Oct 31, 2024 | 5.05 | -2.70 |
Perspective Therapeutics | CATX | Oct 31, 2024 | 11.81 | +2.96 |
Petco Health And Wellness | WOOF | Oct 31, 2024 | 4.27 | -4.90 |
PetIQ A | PETQ | Oct 31, 2024 | 30.98 | 0.00 |
PetMed Express | PETS | Oct 31, 2024 | 4.10 | +1.74 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Oct 31, 2024 | 13.45 | -0.15 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Oct 31, 2024 | 12.37 | -0.32 |
Petros Pharmaceuticals | PTPI | Oct 31, 2024 | 0.37 | -2.63 |
Pfizer | PFE | Oct 31, 2024 | 28.30 | -0.77 |
Pgim Global High Yield Fund | GHY | Oct 31, 2024 | 12.61 | 0.00 |
Pgim High Yield Bond Fund | ISD | Oct 31, 2024 | 14.04 | +0.29 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Oct 31, 2024 | 16.64 | +0.06 |
Pharmaceutical ETF Market Vectors | PPH | Oct 31, 2024 | 91.31 | -0.65 |
PharmaCyte Biotech | PMCB | Oct 31, 2024 | 1.81 | -3.21 |
Pharming Group ADR | PHAR | Oct 31, 2024 | 8.91 | +0.56 |
Pharvaris | PHVS | Oct 31, 2024 | 24.87 | +0.28 |
Phathom Pharmaceuticals | PHAT | Oct 31, 2024 | 17.15 | -1.55 |
PhenixFIN | PFX | Oct 31, 2024 | 47.00 | -1.78 |
Pheton | PTHL | Oct 31, 2024 | 4.00 | 0.00 |
Phibro Animal Health A | PAHC | Oct 31, 2024 | 23.12 | -2.45 |
Philip Morris | PM | Oct 31, 2024 | 132.70 | +0.45 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Oct 31, 2024 | 27.37 | -1.37 |
Phillips 66 | PSX | Oct 31, 2024 | 121.82 | -0.20 |
Phillips Edison & Company | PECO | Oct 31, 2024 | 37.81 | 0.00 |
PHINIA | PHIN | Oct 31, 2024 | 46.58 | +4.67 |
Phio Pharmaceuticals | PHIO | Oct 31, 2024 | 2.98 | -5.40 |
PHLX Semiconductor | SOX | Oct 31, 2024 | 4 946.75 | -4.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.